Immunosuppressive treatment of severe acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zupan
I P
IP
Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia. irena.zupan@kclj.si
Zver
S
S
Pretnar
J
J
D000293:Adolescent; D000328:Adult; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000276:immunology* / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007938:Leukemia / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy; D055728:Primary Myelofibrosis / Q000628:therapy; D012189:Retrospective Studies; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000276:immunology
D007166:Immunosuppressive Agents